Dow Jones

38,686.32

1.51%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

KVB

K V Pharma CL B (KVB)

K V Pharma CL B

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:KVB

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
18/06/2012	08:04	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH	NYSE:KVB	K V Pharma CL B
16/11/2011	19:15	Business Wire	Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
02/11/2011	20:40	Business Wire	Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
31/10/2011	20:30	Business Wire	Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
28/10/2011	15:30	Business Wire	Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
24/10/2011	12:52	Business Wire	The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
13/06/2011	07:00	PR Newswire (US)	K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call	NYSE:KVB	K V Pharma CL B
01/04/2011	14:08	Dow Jones News	UPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid Outcry	NYSE:KVB	K V Pharma CL B
01/04/2011	09:28	Dow Jones News	K-V Pharma Slashes Prices Of Preterm Labor Drug After FDA Move	NYSE:KVB	K V Pharma CL B
31/03/2011	16:28	Dow Jones News	Religious Groups Urge Drug Makers To Ease Up On Price Hikes	NYSE:KVB	K V Pharma CL B
30/03/2011	14:58	Dow Jones News	UPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug	NYSE:KVB	K V Pharma CL B
30/03/2011	11:38	Dow Jones News	K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug	NYSE:KVB	K V Pharma CL B
01/03/2011	07:49	PR Newswire (US)	K-V Pharmaceutical Company Announces $200 Million Private Debt Offering	NYSE:KVB	K V Pharma CL B
14/02/2011	09:34	PR Newswire (US)	K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to Issue	NYSE:KVB	K V Pharma CL B
14/02/2011	08:48	PR Newswire (US)	K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock	NYSE:KVB	K V Pharma CL B
04/02/2011	07:40	PR Newswire (US)	K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011	NYSE:KVB	K V Pharma CL B
12/01/2011	08:03	PR Newswire (US)	K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™	NYSE:KVB	K V Pharma CL B
14/09/2010	09:29	Dow Jones News	K-V Pharmaceutical Enters Loan Agreement In Wake Of FDA Approval	NYSE:KVB	K V Pharma CL B
10/09/2010	08:53	Dow Jones News	K-V Pharma Soars On FDA Approval To Return Product To Market	NYSE:KVB	K V Pharma CL B
20/01/2010	14:41	Dow Jones News	UPDATE: Watson Pharma Benefits From Toprol Market Presence	NYSE:KVB	K V Pharma CL B
20/01/2010	13:11	Dow Jones News	Watson Pharma Continues To Benefit From Toprol Market Presence	NYSE:KVB	K V Pharma CL B
11/01/2010	08:18	PR Newswire (US)	KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)	NYSE:KVB
07/01/2010	15:10	PR Newswire (US)	KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director	NYSE:KVB
15/12/2009	16:26	PR Newswire (US)	KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent	NYSE:KVB
02/12/2009	15:45	PR Newswire (US)	KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet	NYSE:KVB
13/11/2009	15:01	PR Newswire (US)	KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments	NYSE:KVB
07/10/2009	12:54	Dow Jones News	Large Generic Drug Cos Benefiting From Price Stability	NYSE:KVB	K-V Pharmaceutical Co. (Cl B)
21/09/2009	07:30	PR Newswire (US)	KV Pharmaceutical Divests ANDA for Generic Version of Duac(R)	NYSE:KVB
15/09/2009	15:34	PR Newswire (US)	KV Pharmaceutical Receives Stockholder Action by Written Consent	NYSE:KVB
04/09/2009	16:43	PR Newswire (US)	KV Pharmaceutical Appoints Interim Chief Financial Officer	NYSE:KVB